NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness.

MLA

Mizrachi, Tehila, et al. “NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness.” Journal of Immunology Research, vol. 2018, May 2018, p. 5389282. EBSCOhost, https://doi.org/10.1155/2018/5389282.

APA

Mizrachi, T., Brill, L., Rabie, M., Nevo, Y., Fellig, Y., Zur, M., Karussis, D., Abramsky, O., Brenner, T., & Vaknin-Dembinsky, A. (2018). NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness. Journal of Immunology Research, 2018, 5389282. https://doi.org/10.1155/2018/5389282

Chicago

Mizrachi, Tehila, Livnat Brill, Malcolm Rabie, Yoram Nevo, Yakov Fellig, Mayan Zur, Dimitrios Karussis, Oded Abramsky, Talma Brenner, and Adi Vaknin-Dembinsky. 2018. “NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness.” Journal of Immunology Research 2018 (May): 5389282. doi:10.1155/2018/5389282.